MedPath

Action of Probiotics on the Microbiota and Intestinal Permeability in Children With Neurodevelopmental Disorders and Their Influence on the Improvement of Language and Learning

Completed
Conditions
Neurodevelopmental Disorders
Interventions
Dietary Supplement: Probiotic blend
Registration Number
NCT06200935
Lead Sponsor
Instituto de Genética Médica y Molecular
Brief Summary

The study included boys and girls with neurodevelopmental disorders between the ages of 3 and 16 years, belonging to two educational centers in Madrid, attended by children with this type of disorder. Both centers have similar characteristics in terms of the type of feeding and management of the children attending them. The study will be randomized, so that probiotics will be administered to some children and placebos to others; and blinded, so that neither the patient nor his family will know whether probiotic or placebo is administered.

The aim of this project is to study the results obtained on microbiota, intestinal permeability, language, behavior and learning of a probiotic combination that will be administered to children in several educational centers that care for children with neurodevelopmental disorders for 5 months.

Detailed Description

The trial was conducted in 4 stages:

* Probiotic development, which will be randomized, so that some children will receive the probiotic and others placebos, and blinded, so that neither the children nor their relatives will know whether they take placebo or probiotic.

* Initial survey to rule out digestive symptoms and resolve possible doubts. Data will be collected on type of housing, location, number of family members, and others. Collection of fecal samples prior to the administration of the probiotic, to carry out a microbiota and intestinal permeability study.

* Administration of the probiotic preparation or placebo to the subjects for 5 months. Monitoring will be done within each center and in the middle of the treatment the doctors will make a face-to-face visit to see the children.

* In the last phase a new online visit is made where a complete clinical history and a survey to rule out digestive symptomatology are evaluated. A neurocognitive evaluation is also done using the SENA behavioral test. New fecal samples are collected for a microbiota and intestinal permeability study following the same procedure as in the second stage.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Children with neurodevelopmental disorders between 3 and 16 years old
  • Similar characteristics in terms of type of food
Exclusion Criteria
  • Digestive symptomatology: gastroesophageal reflux, abdominal pain, flatulence, dysphagia, abdominal distension or constipation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Children with neurodevelopmental disordersProbiotic blendBoys and girls with neurodevelopmental disorders between 3 and 16 years of age, belonging to two educational centers in Madrid, attended by children with this type of disorders. Both centers have similar characteristics in terms of the type of feeding and management of the children attending them
Primary Outcome Measures
NameTimeMethod
MicrobiotaThrough study completion, an average of 6 months

Examination of fecal samples

Intestinal permeabilityThrough study completion, an average of 6 months

Examination of fecal samples and a complete medical history and a survey aimed mainly at ruling out digestive symptoms

Secondary Outcome Measures
NameTimeMethod
Analyze improvement in language, behavior and learningThrough study completion, an average of 6 months

By monitoring at the school, asking family members and with a face-to-face visit by the doctor.

SENA behavioral test is performed at the end of the study

Analyze the outcome in pre-existing digestive disordersThrough study completion, an average of 6 months

A complete medical history and a survey

Analyze the composition of the microbiota and its improvementThrough study completion, an average of 6 months

By collecting fecal samples

Trial Locations

Locations (1)

Mencía Hermosa Vicente

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath